Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Average Rating of “Moderate Buy” from Brokerages

Posted by Stanley Muller on Jun 24th, 2026

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twelve analysts that are covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $10.50.

A number of research analysts recently issued reports on the stock. Royal Bank Of Canada upgraded shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a report on Wednesday, June 3rd. Barclays decreased their price objective on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a report on Monday, May 18th. Weiss Ratings cut shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. BMO Capital Markets decreased their price objective on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a report on Friday, March 20th. Finally, Truist Financial boosted their price objective on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a report on Wednesday, May 20th.

Get Our Latest Stock Report on Aveanna Healthcare

Aveanna Healthcare Stock Up 3.5%

Shares of NASDAQ:AVAH opened at $8.20 on Wednesday. Aveanna Healthcare has a one year low of $3.73 and a one year high of $10.32. The company has a 50 day moving average of $7.02 and a 200-day moving average of $7.58. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. The stock has a market cap of $1.79 billion, a price-to-earnings ratio of 6.95, a P/E/G ratio of 0.82 and a beta of 1.93.

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last issued its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.13 by $0.05. The company had revenue of $647.92 million during the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The company’s quarterly revenue was up 15.9% on a year-over-year basis. On average, sell-side analysts forecast that Aveanna Healthcare will post 0.65 earnings per share for the current year.

Insider Activity at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Paul R. Vigano sold 7,000,000 shares of Aveanna Healthcare stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total value of $43,680,000.00. Following the transaction, the insider owned 252,899 shares of the company’s stock, valued at approximately $1,578,089.76. The trade was a 96.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of Aveanna Healthcare stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the completion of the transaction, the insider directly owned 252,899 shares in the company, valued at approximately $1,578,089.76. The trade was a 96.51% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 19,967,240 shares of company stock worth $124,764,328. Corporate insiders own 5.30% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of AVAH. AQR Capital Management LLC lifted its stake in Aveanna Healthcare by 21.2% in the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after buying an additional 4,602 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in Aveanna Healthcare by 8.3% in the first quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock valued at $1,842,000 after buying an additional 25,974 shares in the last quarter. Jane Street Group LLC lifted its stake in Aveanna Healthcare by 522.0% in the first quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock valued at $407,000 after buying an additional 63,010 shares in the last quarter. Creative Planning lifted its position in shares of Aveanna Healthcare by 15.1% in the second quarter. Creative Planning now owns 47,025 shares of the company’s stock worth $246,000 after purchasing an additional 6,171 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of Aveanna Healthcare by 65.0% in the second quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company’s stock worth $828,000 after purchasing an additional 62,348 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.